Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA
- Amele, S.
- Peters, L.
- Sluzhynska, M.
- Yakovlev, A.
- Scherrer, A.
- Domingo, P.
- Gerstoft, J.
- Viard, J. P.
- Gisinger, M.
- Flisiak, R.
- Bhaghani, S.
- Ristola, M.
- Leen, C.
- Jablonowska, E.
- Wandeler, G.
- Stellbrink, H.
- Falconer, K.
- Monforte, A. D'Arminio
- Horban, A.
- Rockstroh, J. K.
- Lundgren, J. D.
- Mocroft, A.
- Losso, M.
- Kundro, M.
- Ramos Mejia, J. M.
- Schmied, B.
- Zangerle, R.
- Karpov, I.
- Vassilenko, A.
- Mitsura, V. M.
- Paduto, D.
- Clumeck, N.
- De Wit, S.
- Delforge, M.
- Florence, E.
- Vandekerckhove, L.
- Hadziosmanovic, V.
- Begovac, J.
- Machala, L.
- Jilich, D.
- Sedlacek, D.
- Kronborg, G.
- Benfield, T.
- Gerstoft, J.
- Katzenstein, T.
- Pedersen, C.
- Johansen, I. S.
- Ostergaard, L.
- Wiese, L.
- Moller, N. F.
- Nielsen, L. N.
- Zilmer, K.
- Smidt, Jelena
- Ristola, M.
- Aho, I.
- Viard, J-P
- Girard, P. -M .
- Pradier, C.
- Fontas, E.
- Duvivier, C.
- Rockstroh, J.
- Behrens, G.
- Degen, O.
- Stellbrink, H. J.
- Stefan, C.
- Bogner, J.
- Fatkenheuer, G.
- Chkhartishvili, N.
- Gargalianos, P.
- Xylomenos, G.
- Armenis, K.
- Sambatakou, H.
- Szlavik, J.
- Gottfredsson, M.
- Mulcahy, F.
- Yust, I.
- Turner, D.
- Burke, M.
- Shahar, E.
- Hassoun, G.
- Elinav, H.
- Haouzi, M.
- Elbirt, D.
- Sthoeger, Z. M.
- Monforte, A. D'Arminio
- Esposito, R.
- Mazeu, I.
- Mussini, C.
- Mazzotta, F.
- Gabbuti, A.
- Vullo, V.
- Lichtner, M.
- Zaccarelli, M.
- Antinori, A.
- Acinapura, R.
- Plazzi, M.
- Lazzarin, A.
- Castagna, A.
- Gianotti, N.
- Galli, M.
- Ridolfo, A.
- Rozentale, B.
- Uzdaviniene, V.
- Matulionyte, R.
- Staub, T.
- Hemmer, R.
- Reiss, P.
- Reikvam, D. H.
- Maeland, A.
- Bruun, J.
- Knysz, B.
- Gasiorowski, J.
- Inglot, M.
- Bakowska, E.
- Flisiak, R.
- Grzeszczuk, A.
- Parczewski, M.
- Maciejewska, K.
- Aksak-Was, B.
- Beniowski, M.
- Mularska, E.
- Smiatacz, T.
- Gensing, M.
- Jablonowska, E.
- Kamerys, J.
- Wojcik, K.
- Mozer-Lisewska, I.
- Caldeira, L.
- Mansinho, K.
- Maltez, F.
- Radoi, R.
- Oprea, C.
- Oprea, C.
- Panteleev, A.
- Panteleev, O.
- Yakovlev, A.
- Trofimora, T.
- Khromova, I.
- Kuzovatova, E.
- Borodulina, E.
- Vdoushkina, E.
- Jevtovic, D.
- Tomazic, J.
- Miro, J. M.
- Laguno, M.
- Martinez, E.
- Garcia, F.
- Blanco, J. L.
- Martinez-Rebollar, M.
- Mallolas, J.
- Moreno, S.
- Rodriguez, J. M.
- Clotet, B.
- Jou, A.
- Paredes, R.
- Tural, C.
- Puig, J.
- Bravo, I.
- Domingo, P.
- Gutierrez, M.
- Mateo, G.
- Sambeat, M. A.
- Laporte, J. M.
- Falconer, K.
- Thalme, A.
- Sonnerborg, A.
- Treutiger, C. J.
- Flamholc, L.
- Scherrer, A.
- Weber, R.
- Cavassini, M.
- Calmy, A.
- Furrer, H.
- Battegay, M.
- Schmid, P.
- Kuznetsova, A.
- Kyselyova, G.
- Sluzhynska, M.
- Gazzard, B.
- Johnson, A. M.
- Simons, E.
- Edwards, S.
- Phillips, A.
- Johnson, M. A.
- Mocroft, A.
- Orkin, C.
- Weber, J.
- Scullard, G.
- Clarke, A.
- Leen, C.
- Karpov, I.
- Losso, M.
- Lundgren, J.
- Rockstroh, J.
- Aho, I.
- Rasmussen, L. D.
- Svedhem, V.
- Wandeler, G.
- Pradier, C.
- Chkhartishvili, N.
- Matulionyte, R.
- Oprea, C.
- Kowalska, J. D.
- Begovac, J.
- Miro, J.
- Guaraldi, G.
- Paredes, R.
- Rockstroh, J.
- Mocroft, A.
- Kirk, O.
- Kirk, O.
- Peters, L.
- Bojesen, A.
- Raben, D.
- Kristensen, D.
- Laut, K.
- Larsen, J. F.
- Podlekareva, D.
- Nykjaer, B.
- Mocroft, A.
- Phillips, A.
- Cozzi-Lepri, A.
- Amele, S.
- Elchen-Matthews, A. P.
DOIAbstract
Objectives The aim of the study was to establish a methodology for evaluating the hepatitis C continuum of care in HIV/hepatitis C virus (HCV)-coinfected individuals and to characterize the continuum in Europe on 1 January 2015, prior to widespread access to direct-acting antiviral (DAA) therapy. Methods Stages included in the continuum were as follows: anti-HCV antibody positive, HCV RNA tested, currently HCV RNA positive, ever HCV RNA positive, ever received HCV treatment, completed HCV treatment, follow-up HCV RNA test, and cure. Sustained virological response (SVR) could only be assessed for those with a follow-up HCV RNA test and was defined as a negative HCV RNA result measured > 12 or 24 weeks after stopping treatment. Results Number...
Add to ORKG